Neurogene Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 1.37K shares, a 80.91% decline year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 21.32K shares, a 1167.02% increase year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 5.83K shares, a 34.15% decline year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 6.02K shares, a 72.20% decline year-over-year.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 20.73K shares, a 77.62% decline from fiscal 2024.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 92.65K shares, a 355.34% increase from fiscal 2023.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 20.35K shares, a 44.25% decline from fiscal 2022.
- Neurogene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 36.50K shares, a 70.78% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 1.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 34.55K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 21.32K shares 10-Q · filed 2026-05-12 | 40.38K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 5.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 20.73K shares 10-K · filed 2026-03-24 |
| 2025-09-30 | 6.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 23.76K shares derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | 7.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 39.40K shares derived: sum of 4 quarters · filed 2025-08-11 |
| 2025-03-31 | 1.68K shares 10-Q · filed 2025-05-09 | 57.01K shares derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-12-31 | 8.86K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 92.65K shares 10-K · filed 2025-03-24 |
| 2024-09-30 | 21.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | 104.14K shares derived: sum of 4 quarters · filed 2024-11-18 |
| 2024-06-30 | 24.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | 82.48K shares derived: sum of 4 quarters · filed 2024-08-09 |
| 2024-03-31 | 37.33K shares 10-Q · filed 2024-05-10 | 57.68K shares derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | 20.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | 20.35K shares 10-K · filed 2024-03-18 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 29.20K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 0.00 shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-08 | 0.00 shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-12-31 | 29.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 36.50K shares 10-K · filed 2023-03-20 |
| 2022-09-30 | -29.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 7.86K shares derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 44.57K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | 36.50K shares 10-Q · filed 2023-05-08 | 69.69K shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | 562.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 124.93K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 7.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 425.72K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | 25.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 524.29K shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 91.74K shares 10-Q · filed 2022-05-09 | 598.05K shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 301.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 882.62K shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 106.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 894.26K shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | 98.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 801.29K shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | 376.31K shares 10-Q · filed 2021-05-12 | 702.40K shares derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | 312.99K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 326.09K shares 10-K · filed 2020-03-12 |
| 2019-09-30 | 13.10K shares 10-Q · filed 2019-11-13 | 13.10K shares derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-01 | 0.00 shares derived: sum of 4 quarters · filed 2020-03-12 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-05-07 | 45.21K shares derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 64.94K shares 10-K · filed 2020-03-12 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 72.44K shares derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | 45.21K shares 10-Q · filed 2018-08-08 | 72.66K shares derived: sum of 4 quarters · filed 2018-08-08 |
| 2018-03-31 | 19.73K shares 10-Q · filed 2018-05-08 | 69.01K shares derived: sum of 4 quarters · filed 2018-05-08 |
| 2017-12-31 | 7.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 49.28K shares 10-K · filed 2018-03-12 |
| 2017-09-30 | 218.00 shares 10-Q · filed 2017-11-08 | 41.78K shares derived: sum of 4 quarters · filed 2017-11-08 |
| 2017-06-30 | 41.56K shares 10-Q · filed 2017-08-08 | 96.57K shares derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | 0.00 shares 10-Q · filed 2017-05-09 | 55.66K shares derived: sum of 4 quarters · filed 2017-05-09 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | 55.66K shares 10-K · filed 2017-03-09 |
| 2016-09-30 | 55.01K shares 10-Q · filed 2016-11-09 | 55.66K shares derived: sum of 4 quarters · filed 2016-11-09 |
| 2016-06-30 | 651.00 shares 10-Q · filed 2016-08-04 | 160.42K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-10 | 163.86K shares derived: sum of 4 quarters · filed 2016-05-10 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 191.88K shares 10-K · filed 2016-03-14 |
| 2015-09-30 | 159.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | |
| 2015-06-30 | 4.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | |
| 2015-03-31 | 28.02K shares 10-Q · filed 2015-05-12 | |
| 2014-12-31 | 86.00 shares 10-K · filed 2015-03-16 | |
| 2014-09-30 | 86.00 shares 10-Q · filed 2014-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |